Wnt/β-catenin signaling in development and cancer
Wnt/β-catenin signaling in development and cancer is a research topic within Molecular Biology. Science Explorer counts 22k research works in it since 1961. 26.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the Wnt signaling pathway and its role in development, stem cells, cancer, and disease. It covers components, mechanisms, diseases, therapeutic modalities, and the impact of Wnt signaling on osteoblast and chondrocyte differentiation.
- Wnt Signaling
- ß-Catenin
- Stem Cells
- Cancer
- Development
- GSK-3
- Lipoprotein Receptor
- Cadherin Pathways
- Therapeutic Targets
- Osteoblast Differentiation
- Research works
- 22k fractional, since 1961
- In the world top 10%
- 5.8k per year above
- Top-10% rate
- 26.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -10% the tick is no change
Which countries lead Wnt/β-catenin signaling in development and cancer research?
By volume, China and the United States publish the most (979 and 451 works in 2022–2025).
By volume, 2022–2025
- 1 China 979 works
- 2 United States 451 works
- 3 Japan 136 works
- 4 India 118 works
- 5 Germany 85 works
- 6 South Korea 74 works
- 7 United Kingdom 72 works
- 8 Italy 53 works
- 9 France 53 works
- 10 Iran 47 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Wnt/β-catenin signaling in development and cancer research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Wnt/β-catenin signaling in development and cancer research, followed by China Medical University and Nanjing Medical University.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 12 works
- 2 China Medical UniversityChina 12 works
- 3 Nanjing Medical UniversityChina 12 works
- 4 Sichuan UniversityChina 12 works
- 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 12 works
- 6 Fujian Medical UniversityChina 11 works
- 7 Shanghai Jiao Tong UniversityChina 9 works
- 8 Stanford UniversityUnited States 9 works
- 9 Southern Medical UniversityChina 8 works
- 10 Chongqing Medical UniversityChina 8 works
Where is Wnt/β-catenin signaling in development and cancer research done?
The largest centres of Wnt/β-catenin signaling in development and cancer research in 2022–2025 are Shanghai (China), Beijing (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Fuzhou.
Largest cities, 2022–2025
Where it is the local speciality
- FuzhouCN · 21.2 works4.0×
Location quotient: how much more of its research is in Wnt/β-catenin signaling in development and cancer than the world average.
Where is the best place to study Wnt/β-catenin signaling in development and cancer?
Among universities, judged by research, China Medical University, Sun Yat-sen University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | China Medical UniversityChina | 74.4 | 25.0% | 15.2× | 12 | -21.9% |
| 2 | Sun Yat-sen UniversityChina | 65.9 | 26.5% | 3.1× | 12 | +36.8% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 61.5 | 22.0% | 5.0× | 12 | +43.6% |
| 4 | Fujian Medical UniversityChina | 58.2 | 11.9% | 12.3× | 11 | +142.9% |
| 5 | Sichuan UniversityChina | 57.7 | 25.0% | 2.8× | 12 | +26.2% |
| 6 | Nanjing Medical UniversityChina | 56.0 | 9.5% | 9.6× | 12 | +100.7% |
| 7 | Southern Medical UniversityChina | 55.2 | 20.3% | 9.5× | 8 | +55.4% |
| 8 | Stanford UniversityUnited States | 48.8 | 26.5% | 3.0× | 9 | -45.2% |
| 9 | Chongqing Medical UniversityChina | 45.0 | 16.2% | 9.9× | 8 | +59.8% |
| 10 | Shanghai Jiao Tong UniversityChina | 32.9 | 16.9% | 1.8× | 9 | +36.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Wnt/β-catenin signaling in development and cancer research growing?
Output in 2018–2022 was 10% lower than in 2013–2017, peaking in 2014. The fastest-growing topics are Wnt/β-catenin signaling in development and cancer.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.